Y
Ying Wang
Researcher at University of Texas MD Anderson Cancer Center
Publications - 4
Citations - 227
Ying Wang is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Lung cancer & Medicine. The author has an hindex of 1, co-authored 2 publications receiving 189 citations.
Papers
More filters
Journal ArticleDOI
Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance.
Rodrigo Jacamo,Ye Chen,Zhiqiang Wang,Wencai Ma,Min Zhang,Erika L. Spaeth,Ying Wang,Venkata Lokesh Battula,Po Yee Mak,Katharina Schallmoser,Peter P. Ruvolo,Wendy D. Schober,Elizabeth J. Shpall,Martin Nguyen,Dirk Strunk,Carlos E. Bueso-Ramos,Sergej Konoplev,R. Eric Davis,Marina Konopleva,Michael Andreeff +19 more
TL;DR: It is suggested that reciprocal NF-κB activation in BM-MSCs and leukemia cells is essential for promoting chemoresistance in the transformed cells, and targeting NF- κB-α or VLA-4/VCAM-1 signaling could be a clinically relevant mechanism to overcome stroma-mediated chemores resistance inBM-resident leukemia cells.
mediates chemoresistance B κ Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-
Carlos Bueso-Ramos,Sergej Konoplev,R. Eric Davis,Marina Konopleva,L. Battula,Peter P. Ruvolo,Wendy D. Schober,Elizabeth J. Shpall,Ye Chen,Zhiqiang Wang,Wencai Ma,Erika L. Spaeth,Ying Wang +12 more
Journal ArticleDOI
Use of honokiol in lung cancer therapy: a mini review of its pharmacological mechanism.
TL;DR: In this article , the use of Honokiol (3',5-di-(2-propenyl)-1,1'-biphenyl-2,2'-diol) in the treatment of lung cancer was discussed.
Journal ArticleDOI
Epidemiological and demographic drivers of lung cancer mortality from 1990 to 2019: results from the global burden of disease study 2019
Yaguang Fan,Yong-xiao Jiang,Lei Gong,Ying Wang,Zheng Su,Xuebing Li,Heng Wu,Hongli Pan,Jing Wang,Zhaowei Meng,Qinghua Zhou,Youlin Qiao +11 more
TL;DR: In this paper , the authors examined the drivers of lung cancer mortality at the global, regional, and national levels and found that population aging and population growth increased global lung cancer deaths from 1990 to 2019, despite a decrease in age-specific lung cancer death rates due to GBD risks.